Can-Fite BioPharma Ltd. Deferred Revenue Recognized
Can-Fite BioPharma Ltd. (CANF) reported Deferred Revenue Recognized of $405.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2026-03-26
| Period end | Contract with Customer, Liability, Revenue Recognized 6 month | Contract with Customer, Liability, Revenue Recognized 12 month |
|---|---|---|
| 2025-12-31 | $405.00K 20-F · filed 2026-03-26 | |
| 2025-06-30 | $202.00K 6-K · filed 2025-08-28 | |
| 2024-12-31 | $403.00K 20-F · filed 2025-04-14 |